Bex (compound analgesic)
Historical compound analgesic
Bex was a popular compound analgesic in Australia and New Zealand during the mid-20th century. It was widely used for its pain-relieving properties but later became infamous due to its association with kidney damage and other health issues.
Composition[edit]
Bex was a compound analgesic that typically contained three active ingredients: aspirin, phenacetin, and caffeine. This combination was designed to provide effective relief from pain, fever, and inflammation.
Aspirin[edit]
Aspirin, or acetylsalicylic acid, is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, thereby reducing pain and inflammation.
Phenacetin[edit]
Phenacetin was an analgesic and antipyretic agent. It was later found to be nephrotoxic and carcinogenic, leading to its withdrawal from the market in many countries.
Caffeine[edit]
Caffeine is a central nervous system stimulant that can enhance the pain-relieving effects of aspirin and phenacetin.
History[edit]

Bex was first introduced in the 1920s and quickly became a household name in Australia and New Zealand. It was marketed as a remedy for headaches, colds, and other minor ailments. The product was often consumed in the form of a powder, dissolved in water or tea.
Cultural Impact[edit]
The phrase "a Bex and a good lie down" became part of the Australian vernacular, reflecting the widespread use of the product for quick relief from everyday stresses and discomforts.
Health Concerns[edit]
By the 1960s, medical research began to link the long-term use of compound analgesics like Bex to serious health issues, including analgesic nephropathy, a form of kidney damage. The presence of phenacetin was particularly concerning due to its nephrotoxic effects.
Regulatory Actions[edit]
In response to these health concerns, regulatory actions were taken in the 1970s. Phenacetin was banned in many countries, including Australia, leading to the discontinuation of Bex.
Legacy[edit]

The story of Bex serves as a cautionary tale about the potential risks of over-the-counter medications and the importance of regulatory oversight. It also highlights the need for ongoing research into the safety and efficacy of pharmaceutical compounds.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian